Increased B cell activation is present in JAK2V617F-mutated, CALR-mutated and triple-negative essential thrombocythemia.

YUAN-YEH KUO2018-09-102018-09-102017-05http://europepmc.org/abstract/med/28415571http://scholars.lib.ntu.edu.tw/handle/123456789/399892Increased B cell activation is present in JAK2V617F-mutated, CALR-mutated and triple-negative essential thrombocythemia.journal article10.18632/oncotarget.16381